Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients
- 4 October 2023
- journal article
- editorial
- Published by Wiley in Transplant Infectious Disease
- Vol. 25 (6) , e14161
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus InfectionViruses, 2022
- Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNomeMicroorganisms, 2021
- Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients2020
- Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell TransplantationFrontiers in Immunology, 2020
- T‐cell adoptive immunotherapy for BK nephropathy in renal transplantationTransplant Infectious Disease, 2020
- Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeClinical Transplantation, 2019
- BK polyomavirus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeClinical Transplantation, 2019
- Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical TrialClinical Infectious Diseases, 2018
- Virus-Specific T Cells for the Immunocompromised PatientFrontiers in Immunology, 2017
- Adoptive T Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cytomegalovirus Disease in a Renal Transplant RecipientAmerican Journal of Transplantation, 2015